Indian Journal of Respiratory Care

IJRC Email      Register      Login

VOLUME 13 , ISSUE 2 ( April-June, 2024 ) > List of Articles


Silent Invader—Unrevealing Lethal Encounter with Pulmonary Mucormycosis: A Rare Case Report

Venkat Raj, Deepak Shah, Mohit Bhatia, Munesh K Gupta, B Gowthami, Vijay Kumar, Subham Sahoo, Murli D Saini, Ratesh Buhlan

Keywords : Broad aseptate hyphae, Case report, Endobronchial lung biopsy, Invasive course, Klebsiella pneumoniae, Liposomal amphotericin B, Multidisciplinary approach, Pulmonary mucormycosis, Reverse halo sign, Salvage

Citation Information : Raj V, Shah D, Bhatia M, Gupta MK, Gowthami B, Kumar V, Sahoo S, Saini MD, Buhlan R. Silent Invader—Unrevealing Lethal Encounter with Pulmonary Mucormycosis: A Rare Case Report. Indian J Respir Care 2024; 13 (2):124-127.

DOI: 10.5005/jp-journals-11010-1110

License: CC BY-NC 4.0

Published Online: 18-06-2024

Copyright Statement:  Copyright © 2024; The Author(s).


A 61-year-old male having type 2 diabetes presented in the chest outpatient department with complaints of cough with expectoration, fever for 20 days, coughing out blood, and shortness of breath for 10 days. High-resolution computed tomography (HRCT) of the thorax revealed cavity consolidation in the left upper lobe showing reverse halo sign. Moreover, broad aseptate hyphae branching at right angles were observed in the potassium hydroxide (KOH) wet mount of bronchoalveolar lavage (BAL) sample, suggesting Mucorales. We labeled the case as pulmonary mucormycosis and treated with liposomal amphotericin B with correction of hyperglycemia. The patient initially responded well; however, he succumbed later due to the invasive course of the disease.

PDF Share
  1. Gupta MK, Kumar N, Dhameja N, et al. Laboratory diagnosis of mucormycosis: present perspective. J Family Med Prim Care 2022;11(5):1664–1671. DOI: 10.4103/jfmpc.jfmpc_1479_21
  2. Prakash H, Chakrabarti A. Global epidemiology of mucormycosis. J Fungi (Basel) 2019;5(1):26. DOI: 10.3390/jof5010026
  3. Gupta A, Sharma A, Chakrabarti A. The emergence of post-COVID-19 mucormycosis in India: can we prevent it? Indian J Ophthalmol 2021;69(7):1645–1647. DOI: 10.4103/ijo.IJO_1392_21
  4. Chakravarty J, Gupta MK, Tilak R, et al. COVID-19-associated mucormycosis: a clinico-epidemiological study. J Diabetes Complications 2022;36(9):108284. DOI: 10.1016/j.jdiacomp.2022.108284
  5. Ricci E, Ronchetti S, Pericolini E, et al. Role of the glucocorticoid-induced leucine zipper gene in dexamethasone-induced inhibition of mouse neutrophil migration via control of annexin A1 expression. FASEB J 2017;31(7):3054–3065. DOI: 10.1096/fj.201601315R
  6. Kumar A, Pulle MV, Asaf BB, et al. Covid-associated pulmonary mucormycosis. Lung India. 2022;39(2):100–101. DOI: 10.4103/lungindia.lungindia_95_22
  7. De Pauw B, Walsh TJ, Donnelly JP, et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 2008;46:1813–1821. DOI: 10.1086/588660
  8. Muthu V, Agarwal R, Patel A, et al. Definition, diagnosis, and management of COVID-19-associated pulmonary mucormycosis: Delphi consensus statement from the Fungal Infection Study Forum and Academy of Pulmonary Sciences, India. Lancet Infect Dis 2022;22(9):e240–e253. DOI: 10.1016/S1473-3099(22)00124-4
  9. Danion F, Coste A, Le Hyaric C, et al. What is new in pulmonary mucormycosis? J Fungi (Basel) 2023;9(3):307. DOI: 10.3390/jof9030307
  10. Reed C, Bryant R, Ibrahim AS, et al. Combination polyene-caspofungin treatment of rhino-orbital-cerebral mucormycosis. Clin Infect Dis 2008;47:364–371. DOI: 10.1086/589857
  11. Zheng Z, Zhuang Z, Yang M, et al. Bronchial artery embolization for hemoptysis: a systematic review and meta-analysis. J Interv Med 2021;4(4):172–180. DOI: 10.1016/j.jimed.2021.08.003
  12. Prakash H, Chakrabarti A. Epidemiology of mucormycosis in India. Microorganisms 2021;9(3):523. DOI: 10.3390/microorganisms9030523
  13. Cornely OA, Alastruey-Izquierdo A, Arenz D, et al. Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium. Lancet Infect Dis 2019;19(12):e405–e421. DOI: 10.1016/S1473-3099(19)30312-3
  14. Sachdev SS, Chettiankandy TJ, Sardar MA, et al. A comprehensive review of pathogenesis of mucormycosis with implications of COVID-19: Indian perspective. J Global Oral Health 2021;4(2):116. DOI: 10.25259/JGOH_18_2021
  15. Radchenko C, Alraiyes AH, Shojaee S. A systematic approach to the management of massive hemoptysis. J Thorac Dis 2017;9(Suppl. 10):S1069–S1086. DOI: 10.21037/jtd.2017.06.41
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.